Efficacy and tolerability of recombinant interferon-alpha2b/ribavirin combination therapy for patients with chronic hepatitis C: Out-of-trial audit of first treatment and retreatment.

被引：0
|
作者：
Kumar, D [1 ]
Wallington-Beddoe, C [1 ]
George, J [1 ]
Lin, R [1 ]
Samarasinghe, D [1 ]
Liddle, C [1 ]
Farrell, G [1 ]
机构：
[1] Univ Sydney, Westmead Hosp, Westmead, NSW 2145, Australia
来源：
HEPATOLOGY | 2002年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1748
引用
收藏
页码：600A / 600A
页数：1
相关论文
共 50 条
  • [21] Triple combination of interferon alpha-2b, ribavirin, and amantadine for treatment of chronic hepatitis C
    Younossi, ZM
    Mullen, KD
    Hodnick, S
    Barnes, DS
    Carey, WD
    McCullough, AC
    Easley, K
    Gramlich, T
    Liebermann, BY
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2003, 36 (05) : 427 - 430
  • [22] Ribavirin and interferon alpha-2b combination treatment of chronic hepatitis C is effective in patients with clotting disorders
    Fried, R
    Meili, E
    Peter, K
    Hartmann, S
    Tsakiris, D
    Egger, H
    Marbet, G
    GASTROENTEROLOGY, 2001, 120 (05) : A382 - A383
  • [23] Efficacy of Rebetron (interferon and ribavirin) combination therapy in the treatment of patients with chronic hepatitis C not previously treated with interferon.
    Nelson, JB
    HEPATOLOGY, 2000, 32 (04) : 553A - 553A
  • [24] Ribavirin and interferon-A combination therapy vs interferon-A alone in the retreatment of chronic hepatitis C: A randomized clinical trial
    Bellobuono, A
    Mondazzi, L
    Tempini, S
    Silini, E
    Vicari, F
    Ideo, G
    JOURNAL OF VIRAL HEPATITIS, 1997, 4 (03) : 185 - 191
  • [25] Efficacy of pegylated interferon alpha-2b in combination with ribavirin in patients with chronic hepatitis C non-responders to a previous treatment
    Chousterman, M
    Auray-Cartier, V
    Hagege, H
    Arpurt, JP
    Cassan, P
    Denis, J
    Gargot, D
    Nalet, B
    Nouel, O
    Pariente, A
    Wartelle-Bladou, C
    JOURNAL OF HEPATOLOGY, 2003, 38 : 133 - 134
  • [26] Combination treatment of interferon alpha-2b and ribavirin in comparison to interferon monotherapy in treatment of chronic hepatitis C genotype 4 patients
    El-Zayadi, A
    Selim, O
    Haddad, S
    Simmonds, P
    Hamdy, H
    Badran, HM
    Shawky, S
    ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 31 (06): : 472 - 475
  • [27] A Comparison of Interferon alpha-2a Plus Ribavirin Combination Therapy with Peginterferon alpha-2a Plus Ribavirin Combination Therapy for the Treatment of Chronic Hepatitis C
    Demiraslan, Hayati
    Aygen, Bilgehan
    Yildiz, Orhan
    Soyuer, Isin
    Gokahmetoglu, Selma
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2008, 13 (01): : 12 - 22
  • [28] A randomized trial of pegylated interferon α-2b plus ribavirin in the retreatment of chronic hepatitis C
    Jacobson, IM
    Gonzalez, SA
    Ahmed, F
    Lebovics, E
    Min, AD
    Bodenheimer, HC
    Esposito, SP
    Brown, RS
    Bräu, N
    Klion, FM
    Tobias, H
    Bini, EJ
    Brodsky, N
    Cerulli, MA
    Aytaman, A
    Gardner, PW
    Geders, JM
    Spivack, JE
    Rahmin, MG
    Berman, DH
    Ehrlich, J
    Russo, MW
    Chait, M
    Rovner, D
    Edlin, BR
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (11): : 2453 - 2462
  • [29] The Retreatment of Genotype 4 Chronic Hepatitis C Patients with Pegylated Interferon Alpha-2a and Ribavirin
    Peedikayil, Musthafa
    Al Ashgar, Hamad
    Al Kahtani, Khalid
    Al Sohaibani, Fahad
    Ingvar, Kagevi
    Al Quaiz, Mohammed
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S134 - S134
  • [30] Pegylated interferon-alpha2b plus ribavirin for the treatment of chronic hepatitis C virus genotype 4 infection in patients with normal serum ALT
    Al-Ali, Jaber
    Siddique, Iqbal
    Varghese, Rosh
    Hasan, Fuad
    ANNALS OF HEPATOLOGY, 2012, 11 (02) : 186 - 193
12345